Primary pulmonary hypoplasia

Primary pulmonary hypoplasia (also known as primary lung hypoplasia or idiopathic pulmonary hypoplasia) is a rare congenital developmental anomaly in which the lungs fail to develop fully without an identifiable underlying cause such as diaphragmatic hernia, thoracic skeletal abnormalities, oligohydramnios, or other known secondary factors. The condition affects the respiratory system, with one or both lungs being abnormally small, having reduced numbers of airways, alveoli, and pulmonary vessels. This results in a diminished capacity for gas exchange. Clinical presentation typically occurs at birth or shortly thereafter, with affected neonates showing respiratory distress, tachypnea (rapid breathing), cyanosis (bluish discoloration of the skin due to low oxygen levels), and potentially life-threatening respiratory failure. The severity varies widely depending on the degree of lung underdevelopment; bilateral severe cases carry a very poor prognosis and may be incompatible with life, while milder or unilateral forms may present later in infancy or childhood with recurrent respiratory infections or exercise intolerance. There is no curative treatment for primary pulmonary hypoplasia. Management is primarily supportive and may include supplemental oxygen therapy, mechanical ventilation, surfactant administration, and treatment of pulmonary hypertension with agents such as inhaled nitric oxide. In severe cases, extracorporeal membrane oxygenation (ECMO) may be employed as a bridge therapy. Long-term survivors may require ongoing respiratory support and monitoring for complications including pulmonary hypertension and chronic lung disease. Lung transplantation may be considered in select severe cases. The etiology of the primary form remains largely unknown, though rare familial cases have been reported, suggesting a possible genetic contribution in some instances.

Common questions about Primary pulmonary hypoplasia